Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly Zyprexa IM Launch Planned For 2001; 2Q Sales Top $550 Mil.

Jul 24 2000

• By The Pink Sheet

Related Content

Lilly Sepsis Trial Prompts Biotech-Style Jump In Second Quarter

Jul 10 2000

Zeldox QTc Prolongation Is Less Severe Than Serlect, Pfizer Tells Committee

Jul 24 2000

Zeldox Bold Interaction Warning, Not Black Box, Needed For QTc - Committee

Jul 24 2000

Lilly Zyprexa Zydis

Apr 10 2000

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window